[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Ebrahiminia M, Esmaeili F, Shabani L. In vitro differentiation induction of embryonal carcinoma stem cells into insulin-producing cells by Cichorium intybus L. leaf extract. J Ethnopharmacol. 2019:112214.
Ebrahimkhani MR, Ebisuya M. Synthetic developmental biology: build and control multicellular systems. Curr Opin Chem Biol. 2019;52:9-15.
Ebrahimpour N, Mehrabani M, Iranpour M, Kordestani Z, Mehrabani M, Nematollahi MHadi, Asadipour A, Raeiszadeh M, Mehrbani M. The efficacy of a traditional medicine preparation on second-degree burn wounds in rats. J Ethnopharmacol. 2020:112570.
Ebrahimzadeh-Vesal R, Shokrgozar MAli, Nayernia K, Teimoori-Toolabi L, Miryounesi M, Nourashrafeddin S, Ranji N, Modarressi MHosein. A vector-based system for the differentiation of mouse embryonic stem cells toward germ-line cells. Iran J Basic Med Sci. 2014;17(8):566-570.
Ebrahimzadeh-Vesal R, Shokrgozar MA, Nayernia K, Teimoori-Toolabi L, Estiar MA, Miryounesi M, Nourashrafeddin S, Modarressi MH. MicroRNA profiling during germline differentiation of mouse embryonic stem cells. Cell Mol Biol (Noisy-le-grand). 2015;61(3):84-91.
Echalar B, Dostalova D, Palacka K, Javorkova E, Hermankova B, Cervena T, Zajicova A, Holan V, Rossner P. Effects of antimicrobial metal nanoparticles on characteristics and function properties of mouse mesenchymal stem cells. Toxicol In Vitro. 2022:105536.
Echarri AArana, Struszczak L, Beresford M, Campbell JP, Thompson D, Turner JE. The effects of exercise training for eight weeks on immune cell characteristics among breast cancer survivors. Front Sports Act Living. 2023;5:1163182.
Echecopar C, Abad I, Galán-Gómez V, Del Castillo YMozo, Sisinni L, Bueno D, Ruz B, Pérez-Martínez A. An artificial intelligence-driven predictive model for pediatric allogeneic hematopoietic stem cell transplantation using clinical variables. Eur J Haematol. 2024.
Echecopar C, Rey IDel Val, Galán-Gómez V, González-Pérez C, Del Castillo YMozo, Martínez BGonzález, Pérez-Martínez A. The paradigm of total body irradiation in acute lymphoblastic leukaemia: Therapeutic effectiveness versus the challenges of toxicity. An Pediatr (Engl Ed). 2024.
Echegaray CVázquez, Salvati B, Vivien SDulhoste, Francia MGabriel, Solari CM, Cosentino MSoledad, Guberman A, Perullini M. Design of silica nanocarriers: tuning the release to embryonic stem cells by simple strategies. J Biotechnol. 2022.
Echegaray CVázquez. Unleashing Ascl1: Exploring Cross-Lineage Potential in Reprogramming and Regenerative Frontiers. Cell Reprogram. 2023;25(4):139-141.
Echeverria PC, Bhattacharya K, Joshi A, Wang T, Picard D. The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity. PLoS One. 2019;14(2):e0208287.
Echizenya S, Ishii Y, Kitazawa S, Tanaka T, Matsuda S, Watanabe E, Umekawa M, Terasaka S, Houkin K, Hatta T, et al. Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells. Neuro Oncol. 2019.
Eckardt J-N, Röllig C, Metzeler K, Heisig P, Stasik S, Georgi J-A, Kroschinsky F, Stölzel F, Platzbecker U, Spiekermann K, et al. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles. Commun Med (Lond). 2023;3(1):68.
Ecker V, Brandmeier L, Stumpf M, Giansanti P, Moreira AVarela, Pfeuffer L, Fens MHAM, Lu J, Kuster B, Engleitner T, et al. Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression. Cell Rep. 2023;42(10):113017.
Eckert C, Parker C, Moorman AV, Irving JAe, Kirschner-Schwabe R, Groeneveld-Krentz S, Révész T, Hoogerbrugge P, Hancock J, Sutton R, et al. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials. Eur J Cancer. 2021;151:175-189.
Eckert A, Huang L, Gonzalez R, Kim H-S, Hamblin MH, Lee J-P. Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke. Stem Cells Transl Med. 2015.
Eckert MA, Vu PQ, Zhang K, Kang D, M Ali M, Xu C, Zhao W. Novel molecular and nanosensors for in vivo sensing. Theranostics. 2013;3(8):583-94.
Eckert RL, Fisher ML, Grun D, Adhikary G, Xu W, Kerr C. Transglutaminase is a tumor cell and cancer stem cell survival factor. Mol Carcinog. 2015.
Eckert F, Ganser K, Bender B, Schittenhelm J, Skardelly M, Behling F, Tabatabai G, Stransky N, Hoffmann E, Zips D, et al. Potential of pre-operative MRI features in glioblastoma to predict for molecular stem cell subtype and patient overall survival. Radiother Oncol. 2023:109865.
Eckert RL. Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target. Mol Carcinog. 2019.
Eckert C, Groeneveld-Krentz S, Kirschner-Schwabe R, Hagedorn N, Chen-Santel C, Bader P, Borkhardt A, Cario G, Escherich G, Panzer-Grümayer R, et al. Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics. J Clin Oncol. 2019:JCO1901694.
Eckstein OS, Wang L, Punia JN, Kornblau SM, Andreeff M, Wheeler DA, Goodell MA, Rau RE. Mixed Phenotype Acute Leukemia (MPAL) Exhibits Frequent Mutations in DNMT3A and Activated Signaling Genes. Exp Hematol. 2016.
Economides MP, McCue D, Lane AA, Pemmaraju N. Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm. Expert Rev Clin Pharmacol. 2019.
Economou C, Tsakiridis A, Wymeersch FJ, Gordon-Keylock S, Dewhurst RE, Fisher D, Medvinsky A, Smith AJh, Wilson V. Intrinsic factors and the embryonic environment influence the formation of extragonadal teratomas during gestation. BMC Dev Biol. 2015;15(1):35.